Phase 3 Study Program (MGT-RPGR-021 and MGT-RPGR-022) of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated with Variants in the
RPGR
gene
Reset Password
E-Mail Address
Send Password Reset Link
